Pharma Journalist -

Novo Nordisk announced that Rebinyn, Coagulation Factor IX (Recombinant), GlycoPEGylated, is now available in the United States for the treatment of hemophilia B. Rebinyn is an…
Read More...

Sosei Group Corporation announces that its immuno-oncology collaboration with AstraZeneca is progressing well. The first patient has been dosed in an expansion cohort in the Phase 1b…
Read More...

Selvita S.A. (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, announced the…
Read More...

Cancer Research UK launches an international study to answer the final questions before aspirin could be recommended to reduce cancer risk. Studies have estimated that widespread…
Read More...

Roivant Sciences and ArQule announced the initiation of a collaboration to pursue the development of derazantinib, a pan-FGFR (fibroblast growth factor receptor) inhibitor, in Greater…
Read More...

Xcovery announced the initiation of its Phase 2 clinical trial of ensartinib (X-396), the company’s lead anaplastic lymphoma kinase (ALK) drug candidate, in patients with advanced…
Read More...

Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted CAP-1002, its lead investigational cell therapy for the treatment of Duchenne muscular…
Read More...

ORICULA THERAPEUTICS, LLC., a biotech company introducing medications to preserve hearing and balance, announced FDA permission to begin volunteer human testing for safety,…
Read More...

NetVation DL Medicine announced that it has entered into a two-year research collaboration with Pfizer Inc (NYSE: PFE). Under the terms of the agreement, DL Medicine will screen and…
Read More...

Liquidia Technologies announced the appointment of Kevin Gordon as President and Chief Financial Officer. Mr. Gordon will oversee finance operations and strategy, corporate development…
Read More...